default

Request a Quote

Industry Insights

  1. July 22, 2024

    AMR: An Evolving Global Health Threat

    The World Health Organization (WHO) recently released its 2024 Bacterial Priority Pathogens List (BPPL). The 72-page document builds on its first list, released in 2017. The WHO BPPL 2024 focuses on the antibiotic-resistant bacteria that present the greatest unmet needs and pose the most significant public health burdens. The list includes 15 families of antibiotic resistant pathogens grouped as critical, high and medium categories.

    Read More
  2. July 15, 2024

    Tuberculosis: Still the Deadliest Infectious Disease in the World

    For a human pathogen with no known environmental reservoir, Mycobacterium tuberculosis has honed the art of survival and has persisted in human communities from antiquity through modern times. Tuberculosis is a preventable and treatable infectious disease. Having said that, it is still one of the major contributors to morbidity and mortality in developing countries where there is less-than-adequate access to care.

    Read More
  3. July 01, 2024

    Is progress being made against Cystic Fibrosis?

    We’re all familiar with this ever-present dichotomy. Antibiotics are life-saving, until they’re not; until the delicate balance shifts, causing the oh-so-inevitable resistance. While antibiotic stewardship programs are becoming more and more prevalent, what does one do when working with a patient with a chronic condition in which daily, long-term antimicrobial treatment is the norm? How do we address antimicrobial resistance (AMR) in patients with whom bacterial infections are typically never fully eradicated, despite the employment of a multitude of drug therapies?

    Read More
  4. June 24, 2024

    Early antibiotic use increases risk of colon cancer

    In a large genetic analysis study, individuals with genetic risk factors, such as family history of colorectal cancer (CRC), who have experienced early-life antibiotic use on a long term basis, demonstrated an increased risk of early-onset CRC. It was determined that individuals with a high polygenic risk score (genetic predisposition to a particular disease) were at higher risk of early-onset CRC, further supporting the association between antibiotic use and early-onset CRC with genetic risk factors.

    Read More
  5. May 21, 2024

    Pan-Resistant Candida auris

    The CDC attributes the rise in C. auris cases during the height of the pandemic as a result of inadequate staffing, supply shortages, the increased number of seriously ill patients, and changes in infection prevention and control practices. The CDC encourages all U.S. laboratories that identify C. auris to notify their state or local public health authorities. 

    Read More
  6. April 10, 2024

    Meningococcal Meningitis on the Rise

    The CDC is alerting doctors to be on the lookout for certain types of rare, serious meningococcal infections that are on the rise in the United States.

    This alarming increase is caused by Neisseria meningitidis bacteria, which has caused 1 in 6 people to die, a higher fatality rate than they typically see with meningococcal infections.

    These cases are also unusual because they are striking middle-aged adults. Typically, meningitis infections strike babies or adolescents and young adults.

    Read More
  7. April 03, 2024

    Turning the Tide: The NSCSS Task Force's Battle Against Rising Syphilis Rates

    The Centers for Disease Control and Prevention (CDC) recently released its 2022 Sexually Transmitted Infections (STI) Surveillance Report providing U.S. data for nationally notifiable STI’s for federally funded control programs.

    According to the report, syphilis cases (all stages and congenital syphilis) increased 80 percent from 2018-2022. More than 3,700 congenital syphilis cases were reported in 2022, reflecting an alarming 937 percent increase in the past decade, said Laura Bachmann, MD, MPH, Acting Director, CDC’s Division of STD Prevention in her announcement letter included in the report.

    Read More
  8. March 14, 2024

    Why Public Health Depends Upon Antimicrobial Stewardship

    As hundreds of thousands of patients come face-to-face with health issues related to antibiotic-resistant infections, the scientific community must address the significance of antimicrobial stewardship and its core principles.

    Read More
  9. February 28, 2024

    Anaerobic Culture Media's Crucial Role in Diagnosing Unique Gas Gangrene Case

    Postoperative infections are one of the most common complications in general surgery, and rates have been reduced with the routine administration of perioperative antibiotics (1). GG is reportedly more common after penetrating trauma or major surgery and is rarely reported without obvious predisposing events, such as edema, fever, malaise, and pain. Previous documents have only reported gas gangrene once after an open rectal surgery or laparoscopic cholecystectomy (2, 3). However, the authors of the case documented in the Frontiers in Surgery report say this is the first case of GG of the pelvic wall, after laparoscopic resection for rectal cancer, occurred.

    Read More
  10. February 05, 2024

    Mastering the Kirby-Bauer Technique: From Zones to Results

    The purpose of the Kirby-Bauer disk diffusion susceptibility test is to determine the in vitro susceptibility of bacteria and fungi to various antimicrobial compounds. It is a standardized test that can be performed in a laboratory setting and is a valuable tool for both clinicians and microbiologists.

    Read More
  11. January 12, 2024

    Cases of Group A Streptococcus Continue to Climb

    We began to see an increase in the number of strep throat cases in beginning in late spring of 2023, not only in pediatric patients, but adults as well. Now in December, cases of Group A Streptococcus (GAS) continue to rise. During one newscast out of the Midwest, some physicians say 2023 was the worst year for strep throat that they can remember.
    Read More
  12. January 10, 2024

    Hep C: An Anti-Viral Success Story

    Hepatitis C is the primary cause of liver cancer and the need for liver transplants among patients infected with the virus.

    Infection is often the result of coming into contact with contaminated blood, usually through injected drug use, but also

    ...
    Read More
  13. January 04, 2024

    Training Guide for NG-Test® CARBA 5

    Carbapenem-resistant Enterobacterales or CRE, are a group of gram-negative bacteria that are resistant to “last line” antibiotics and are very challenging to treat. These microorganisms may confer their resistance via the production of a carbapenemase, an enzyme that inactivates carbapenem antibiotics.

    The five most common types of carbapenemases are KPC, OXA-48-like, VIM, IMP, and NDM.

    Knowing the type of carbapenemase is crucial for therapeutic purposes, infection control, and for preventing outbreaks.

    Read More
  14. October 09, 2023

    New Recommendations to Combat Rising Rates of MRSA Infections

    ...
    Read More
  15. September 20, 2023

    Hydrogen Peroxide Fogging Shown to Significantly Reduce C. difficile Infections

    ...
    Read More
Page